Jerini AG
FRA:JI4 ISIN:DE0006787476
Jerini AG (FRA:JI4) is a pharmaceutical company based in Berlin, Germany. Shire Limited's German wholly-owned indirect subsidiary Shire Deutschland Investments GmbH currently holds 100 percent of Jerini’s shares. Jerini is a subsidiary of Shire plc and a member of the Shire group of companies.
News
Jerini AG (OJ:JI4) Berlin, November 14, 2008 - Jerini AG (FSE:JI4) reported financial results according to International Financial Reporting Standards (IFRS) for the first nine months ended September 30, 2008.
Jerini AG (OJ:JI4) Jerini AG / Misc. matters / Ad hoc: Strategic Review of Jerini Assets Completed Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
* Joint reasoned statement from Management Board and Supervisory Board published * Offer of EUR 6.25 per share determined to be fair * Shire's expertise will ensure Firazyr®'s successful commercialisation in Europe and support its potential marketing approval in the USA * Shire currently holds a stake of more than 80 percent in Jerini * Acceptance period ends on September 10, 2008 * Offer is not subject to any offer conditions
###
1,423 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 10) (Since Published: 1423)
